These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Emerging role of non-coding RNA in oral cancer. Momen-Heravi F; Bala S Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500 [TBL] [Abstract][Full Text] [Related]
24. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines. Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292 [TBL] [Abstract][Full Text] [Related]
25. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling. Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis. Imura T; Mitsuhara T; Horie N Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057 [TBL] [Abstract][Full Text] [Related]
27. miR-497 and 219 in blood aid meningioma classification. Abdelrahman A; Negroni C; Sahm F; Adams CL; Urbanic-Purkart T; Khalil M; Vergura R; Morelli C; Hanemann CO J Neurooncol; 2022 Oct; 160(1):137-147. PubMed ID: 36076132 [TBL] [Abstract][Full Text] [Related]
28. Secretory miRNAs as novel cancer biomarkers. Zhang J; Zhao H; Gao Y; Zhang W Biochim Biophys Acta; 2012 Aug; 1826(1):32-43. PubMed ID: 22440944 [TBL] [Abstract][Full Text] [Related]
29. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061 [TBL] [Abstract][Full Text] [Related]
30. LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway. Li T; Ren J; Ma J; Wu J; Zhang R; Yuan H; Han X Biomed Pharmacother; 2019 May; 113():108718. PubMed ID: 30849635 [TBL] [Abstract][Full Text] [Related]
31. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas. Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614 [TBL] [Abstract][Full Text] [Related]
32. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications. Xie SS; Jin J; Xu X; Zhuo W; Zhou TH World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers. Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661 [TBL] [Abstract][Full Text] [Related]
37. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969 [TBL] [Abstract][Full Text] [Related]
38. The Dual Role of MicroRNAs in Colorectal Cancer Progression. Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605 [TBL] [Abstract][Full Text] [Related]